Clinical Trials
3
Active:2
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Oral Administration of Anti-CD3 Monoclonal Antibody in Non-responder Genotype-I Chronic Hepatitis C Subjects
Phase 2
- Conditions
- Chronic Hepatitis C
- Interventions
- Drug: Sodium Chloride placebo
- First Posted Date
- 2011-10-25
- Last Posted Date
- 2011-10-25
- Lead Sponsor
- Inspira Medical AB
- Target Recruit Count
- 36
- Registration Number
- NCT01459419
- Locations
- 🇦🇹
Univ.Klinik für Innere Medizin IV, Wien, Austria
🇵🇱Katedra i Klinika Chorób Zakaźnych i Hepatologii Wojewódzki Szpital Obserwacyjno - Zakaźny im. Tadeusza Browicza, Bydgoszcz, Poland
News
No news found